25 related articles for article (PubMed ID: 38497886)
1. Development and verification of a manganese metabolism- and immune-related genes signature for prediction of prognosis and immune landscape in gastric cancer.
Han X; Leng C; Zhao S; Wang S; Chen S; Wang S; Zhang M; Li X; Lu Y; Wang B; Qi W
Front Immunol; 2024; 15():1377472. PubMed ID: 38807601
[TBL] [Abstract][Full Text] [Related]
2. Identification of disulfidptosis-associated genes and characterization of immune cell infiltration in thyroid carcinoma.
Song S; Zhou J; Zhang L; Sun Y; Zhang Q; Tan Y; Zhou X; Yu J
Aging (Albany NY); 2024 Jun; 16():. PubMed ID: 38836761
[TBL] [Abstract][Full Text] [Related]
3. Prediction of the survival status and tumor microenvironment in colorectal cancer through genotyping analysis based on toll-like receptors.
Peng H; Zhang J; Yang Z; Chen L; Chen J; Cai C
Saudi J Gastroenterol; 2024 May; ():. PubMed ID: 38813725
[TBL] [Abstract][Full Text] [Related]
4. Multiplex immunohistochemistry defines two cholesterol metabolism patterns predicting immunotherapeutic outcomes in gastric cancer.
Tang W; Li G; Lin Q; Zhu Z; Wang Z; Wang Z
J Transl Med; 2023 Dec; 21(1):887. PubMed ID: 38062450
[TBL] [Abstract][Full Text] [Related]
5. Identification of the CD8+ T-cell Related Signature for Predicting the Prognosis of Gastric Cancer Based on Integrated Analysis of Bulk and Single-cell RNA Sequencing Data.
Zhu ZG; Wang Z; Wu Q; Miao DL; Jin YQ; Chen L
J Immunother; 2024 May; ():. PubMed ID: 38809517
[TBL] [Abstract][Full Text] [Related]
6. Integrated analysis reveals a novel 5-fluorouracil resistance-based prognostic signature with promising implications for predicting the efficacy of chemotherapy and immunotherapy in patients with colorectal cancer.
Hou Y; Zhang F; Zong J; Li T; Gan W; Lv S; Yan Z; Zeng Z; Yang L; Zhou M; Zhao W; Yang M
Apoptosis; 2024 Jun; ():. PubMed ID: 38824480
[TBL] [Abstract][Full Text] [Related]
7. Integrated analysis of multiple transcriptomic approaches and machine learning integration algorithms reveals high endothelial venules as a prognostic immune-related biomarker in bladder cancer.
Zhang J; Huang Y; Tan X; Wang Z; Cheng R; Zhang S; Chen Y; Jiang F; Tan W; Deng X; Li F
Int Immunopharmacol; 2024 Jun; 136():112184. PubMed ID: 38824904
[TBL] [Abstract][Full Text] [Related]
8. Identification of the biological functions and chemo-therapeutic responses of ITGB superfamily in ovarian cancer.
Han J; Lyu L
Discov Oncol; 2024 May; 15(1):198. PubMed ID: 38814534
[TBL] [Abstract][Full Text] [Related]
9. A pathways-based prediction model for classifying breast cancer subtypes.
Wu T; Wang Y; Jiang R; Lu X; Tian J
Oncotarget; 2017 Aug; 8(35):58809-58822. PubMed ID: 28938599
[TBL] [Abstract][Full Text] [Related]
10. Harnessing genetic interactions for prediction of immune checkpoint inhibitors response signature in cancer cells.
Liu M; Zhao Z; Wang C; Sang S; Cui Y; Lv C; Yang X; Zhang N; Xiong K; Chen B; Dong Q; Liu K; Gu Y
Cancer Lett; 2024 May; 594():216991. PubMed ID: 38797232
[TBL] [Abstract][Full Text] [Related]
11. Unraveling metabolic characteristics and clinical implications in gastric cancer through single-cell resolution analysis.
Wang W; Li C; Dai Y; Wu Q; Yu W
Front Mol Biosci; 2024; 11():1399679. PubMed ID: 38831933
[No Abstract] [Full Text] [Related]
12. Identification of an Autophagy-Related Signature for Prognosis and Immunotherapy Response Prediction in Ovarian Cancer.
Ding J; Wang C; Sun Y; Guo J; Liu S; Cheng Z
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830707
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive profiling of endocrine metabolism identifies a novel signature with robust predictive value in ovarian cancer.
Yu D; Luo Y; Guo R; Ma F; Chang Y; Dang J
J Gene Med; 2024 May; 26(5):e3686. PubMed ID: 38689382
[TBL] [Abstract][Full Text] [Related]
14. Functional enrichment analysis of LYSET and identification of related hub gene signatures as novel biomarkers to predict prognosis and immune infiltration status of clear cell renal cell carcinoma.
Chen Y; He J; Jin T; Zhang Y; Ou Y
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16905-16929. PubMed ID: 37740762
[TBL] [Abstract][Full Text] [Related]
15. Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq.
Zhang D; Lu W; Cui S; Mei H; Wu X; Zhuo Z
J Ovarian Res; 2022 Nov; 15(1):123. PubMed ID: 36424614
[TBL] [Abstract][Full Text] [Related]
16. 5 signature genes revealed by single-cell profiling identified unique immune subtypes affecting the prognosis of ovarian cancer.
Xiang SY; Li QK; Yang Z; Yi Q
Eur Rev Med Pharmacol Sci; 2024 Mar; 28(5):2051-2062. PubMed ID: 38497886
[TBL] [Abstract][Full Text] [Related]
17. An immune-related exosome signature predicts the prognosis and immunotherapy response in ovarian cancer.
Zhu K; Ma J; Tian Y; Liu Q; Zhang J
BMC Womens Health; 2024 Jan; 24(1):49. PubMed ID: 38238671
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
